Filter
670
Text search:
pharmaceutical
industry
Featured
Recommendations
48
New Publications
160
Language
Document type
No document type
301
Studies & Reports
170
Guidelines
107
Strategic & Response Plan
40
Manuals
27
Fact sheets
8
Situation Updates
7
Training Material
2
Brochures
2
Resource Platforms
2
Infographics
2
Online Courses
2
Countries / Regions
Global
34
India
31
Kenya
30
South Africa
21
Ethiopia
16
Uganda
14
Sierra Leone
13
Nepal
13
Nigeria
12
Ghana
12
Bangladesh
11
Namibia
9
Africa
9
Philippines
8
Tanzania
8
Western and Central Europe
8
Zimbabwe
7
Zambia
7
Syria
7
Myanmar / Burma
7
Latin America and the Carribbean
7
Rwanda
6
Indonesia
6
West and Central Africa
6
Malawi
5
Ukraine
5
Botswana
5
Mozambique
4
South–East Asia Region
4
Asia
4
Eastern Europe
4
Pakistan
3
Thailand
3
Eswatini/ Swaziland
3
Lesotho
3
East and Southern Africa
3
Liberia
2
Senegal
2
Haiti
2
Jordan
2
Afghanistan
2
Cambodia
2
China
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Venezuela
2
Laos
2
Vietnam
2
Burkina Faso
1
Congo, Democratic Republic of
1
Mali
1
USA
1
Saudi Arabia
1
South Sudan
1
Germany
1
Lebanon
1
Egypt
1
Sudan
1
Benin
1
Central African Republic
1
Brazil
1
Colombia
1
Sri Lanka
1
Chile
1
Western Pacific Region
1
Albania
1
Tajikistan
1
Lithuania
1
Moldova
1
Iran
1
Kyrgyzstan
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
242
Clinical Guidelines
37
Public Health
26
Key Resources
25
Pharmacy & Technologies
15
Women & Child Health
10
Capacity Building
4
Annual Report MEDBOX
2
Toolboxes
AMR
113
Pharmacy
62
COVID-19
54
HIV
30
Mental Health
30
Planetary Health
22
Global Health Education
20
NCDs
19
TB
17
NTDs
16
Rapid Response
15
Health Financing Toolbox
15
Ebola & Marburg
10
Conflict
8
Caregiver
7
2.0 Rapid Response
7
Specific Hazards
6
Malaria
4
Disability
3
Refugee
3
Polio
2
Zika
2
Cholera
1
Natural Hazards
1
The Ebola outbreak that started in December 2013 became a public
health, humanitarian and socioeconomic crisis with a devastating
impact on families, communities and affected countries. It also served
as a reminder that the world, including WHO, is ill-prepared for a large
and sustained disease
...
Updated 25 January 2021
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug
...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
21.12.2020
Available in English, Spanish, Italian and Portuguese
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly
...
Explore best practise in pharmacy, and learn how to start a career as a pharmacist, with these online pharmacy courses from FutureLearn.
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR,
infection prevention and control. It will support nurses on better action and also on communication towards
their patients and families.
Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
An international field study by African and German Theologicans and health workers
STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems. With stakeholders expressing concern over issues
...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...